Pilot study to assess bone effects of Cosentyx in ankylosing spondylitis
Healio Rheumatology reported that HSS rheumatologist Susan M. Goodman, MD, and researchers are currently enrolling patients for a study to determine the effects of secukinumab on the skeleton among those with ankylosing spondylitis.
"It's very important to get a better understanding in a practical way of the effect of these drugs on bone metabolism. This study should really help us understand how they work," said Dr. Goodman.
Dr. Goodman noted that she anticipates the study will require two years to complete.
Read the full article at healio.com [subscription required].